The global fertility market size accounted for USD 39.27 billion in 2025 and is forecasted to hit around USD 85.53 billion by 2034, representing a CAGR of 9.03% from 2025 to 2034. The Europe market size was estimated at USD 12.16 billion in 2024 and is expanding at a CAGR of 7.38% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: fertility Industry Impact
5.2. fertility Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and fertility Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for fertility Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Declining fertility rates across the globe
6.1.1.2. Rising number of fertility clinics worldwide, coupled with technological advancements
6.1.2. Market Restraints
6.1.2.1. High procedural cost of assisted reproductive techniques in developed markets
6.1.3. Market Opportunities
6.1.3.1. Use of fertility treatment options by single parents and same-sex couples
7.1. Market Players Landscape
7.1.1. List of Suppliers
7.1.2. List of End-users
8.1. fertility Market, by Offering
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Forecast
8.1.1.2. IVF
8.1.1.3. Market Revenue and Forecast
8.1.1.4. Artificial Insemination
8.1.1.5. Market Revenue and Forecast
8.1.1.6. Surrogacy
8.1.1.7. Market Revenue and Forecast
8.1.1.8. Others
8.1.1.9. Market Revenue and Forecast
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Forecast
8.1.2.2. Gonadotropin
8.1.2.3. Market Revenue and Forecast
8.1.2.4. Anti-estrogen
8.1.2.5. Market Revenue and Forecast
8.1.2.6. Others
8.1.2.7. Market Revenue and Forecast
9.1. fertility Market, by Grade
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Offering
10.1.2. Market Revenue Forecast by End-user
10.1.3. U.S
10.1.3.1. Market Revenue Forecast
10.1.4. Canada
10.1.4.1. Market Revenue Forecast
10.2. Europe
10.2.1. Market Revenue Forecast by Offering
10.2.2. Market Revenue Forecast by End-user
10.2.3. UK
10.2.3.1. Market Revenue Forecast
10.2.4. Germany
10.2.4.1. Market Revenue Forecast
10.2.5. France
10.2.5.1. Market Revenue Forecast
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Offering
10.3.2. Market Revenue Forecast by End-user
10.3.3. China
10.3.3.1. Market Revenue Forecast
10.3.4. India
10.3.4.1. Market Revenue Forecast
10.3.5. Japan
10.3.5.1. Market Revenue Forecast
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast
10.4. LATAM
10.4.1. Market Revenue Forecast by Offering
10.4.2. Market Revenue Forecast by End-user
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Offering
10.5.2. Market Revenue Forecast by End-user
10.5.3. GCC
10.5.3.1. Market Revenue Forecast
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast
11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. INVO Bioscience
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. San Diego Fertility Center
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Celmatix
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Carolinas Fertility Institute
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Progyny Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. Cook Medical
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. LifeGlobal Group (Cooper Surgical)
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample